Y

ou know about fake news, but what about fake drug ads?

Deceptive pharmaceutical advertising has popped up before, but now the US Food and Drug Administration wants to know the extent to which doctors and consumers can actually recognize misleading or false promotions.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Can we run a similar test on the FDA Center for Devices, to see how many mercury-containing devices would be approved outside of the Dental Products Unit? Could we also run these tests on the FDA’s Centers that test for safety and set standards for disclosure of ingredients, side effect and health risks for prescription drugs, OTCs and Personal Care Products? Additionally, can we run this test on the U.S. Consumer Product Safety Commission as a control group?

    Patients have to be concerned about FDA’s own “Fake Safety Approvals” probably even more than Fake Ads, but these are tragically quite real. Only a small percentage of Americans have any idea that dental amalgam, marketed as “silver fillings,” are 50% mercury, which off-gasses with heat and abrasion, and that the “tiny amounts” that are not harmful to the larger population can be quite harmful to a significant subgroup with common genetic susceptibilities as they age (and to some boys sooner, according to four articles published by James S. Woods et al. 2011-2014 retracting the findings of safety from the Children’s Amalgam Trial). Many legislators and policymakers think we banned dental amalgam years ago. So it appears the FDA is aiding, abetting and creating its own “Fake News.”

Recommended Stories

Sign up for our
Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine — delivered straight to your inbox every weekday afternoon.